Frontline Brentuximab Vedotin As Monotherapy or in Combination for Older Hodgkin Lymphoma PatientsChristopher A. Yasenchak, Jonathan W. Friedberg, Jerome H. Goldschmidt et al.|Blood|2020Cited by 16
Frontline brentuximab vedotin as monotherapy or in combination for older Hodgkin lymphoma patients.Christopher A. Yasenchak, Jonathan W. Friedberg, Rodolfo Bordoni et al.|Journal of Clinical Oncology|2020Cited by 3